Abate, ME; Paioli, A; Cesari, M; Longhi, A; Palmerini, E; Setola, E; Carretta, E; Cammelli, S; Ronchi, L; Rocca, M; Manfrini, M; Scotlandi, K; Donati, DM, Toxicity and efficacy of busulfan-melphalan (BuMel) compared to treosulfan-melphalan (TreoMel) high dose chemotherapy (HDCT) consolidation in high-risk Ewing sarcoma (ES): A 12-year monoinstitutional experience, «JOURNAL OF CLINICAL ONCOLOGY», 2019, 37, pp. 1 - 1 [abstract]
Manara, Maria Cristina; Valente, Sergio; Cristalli, Camilla; Nicoletti, Giordano; Landuzzi, Lorena; Zwergel, Clemens; Mazzone, Roberta; Stazi, Giulia; Arimondo, Paola B; Pasello, Michela; Guerzoni, Clara; Picci, Piero; Nanni, Patrizia; Lollini, Pier-Luigi; Mai, Antonello; Scotlandi, Katia, A Quinoline-Based DNA Methyltransferase Inhibitor as a Possible Adjuvant in Osteosarcoma Therapy, «MOLECULAR CANCER THERAPEUTICS», 2018, 17, pp. 1881 - 1892 [articolo]
Mattioli, Elisabetta; Andrenacci, Davide; Garofalo, Cecilia; Prencipe, Sabino; Scotlandi, Katia; Remondini, Daniel; Gentilini, Davide; Di Blasio, Anna Maria; Valente, Sergio; Scarano, Emanuela; Cicchilitti, Lucia; Piaggio, Giulia; Mai, Antonello; Lattanzi, Giovanna, Altered modulation of lamin A/C-HDAC2 interaction and p21 expression during oxidative stress response in HGPS, «AGING CELL», 2018, 17, pp. e12824 - e12839 [articolo]Open Access
Mancarella, Caterina; Pasello, Michela; Ventura, Selena; Grilli, Andrea; Calzolari, Linda; Toracchio, Lisa; Lollini, Pier Luigi; Donati, Davide Maria; Picci, Piero; Ferrari, Stefano; Scotlandi, Katia, Insulin-like growth factor 2 mRNA-binding protein 3 is a novel post-transcriptional regulator of Ewing sarcoma malignancy, «CLINICAL CANCER RESEARCH», 2018, 24, pp. 3704 - 3716 [articolo]
E. Palmerini, R. L. Jones, E. Setola, P. Picci, E. Marchesi,, R. Luksch, G. Grignani, M. Cesari, A. Longhi, M. E. Abate, A. Paioli, Z. Szucs, L. D’ambrosio, K. Scotlandi, F. Fagioli, S. Asaftei, S. Ferrari, Irinotecan and temozolomide in recurrent Ewing sarcoma: an analysis in 51 adult and pediatric patients, «ACTA ONCOLOGICA», 2018, 57, pp. 958 - 964 [articolo]
Balestra T, Manara MC, Scotlandi K, The role of zyxin as a mediator between CD99 and EWS-FLI1, in: Childhood Cancer Research Initiatives, 2018(atti di: Childhood Cancer Research Initiatives, Vienna, 18-20/10/2018) [atti di convegno-poster]
Balestra T, Manara MC, Scotlandi K, Zyxin in Ewing sarcoma: a novel role as mediator between CD99 and EWS-FLI1, in: 60th Annual Meeting of SIC, 2018, pp. 1 - 1 (atti di: 60th Annual Meeting of SIC (Italian Cancer Society), Milan, 19-22/09/2018) [atti di convegno-abstract]
Emanuela Palmerini; Michela Pasello; Robin Lewis Jones; Maria Cristina Manara; Alessandro Parra; Piero Picci; Giovanni Grignani; Emanuela Marchesi; Marilena Cesari; Alessandra Longhi; Massimo Abate; Anna Paioli; Lorenzo D'Ambrosio; Franca Fagioli; Asaftei sebastian Dorin; Stefano Ferrari; Katia Scotlandi, Does MGMT (O6-methylguanine–DNA methyltransferase) have a role in metastatic Ewing sarcoma (ES) patients (pts) undergoing temozolomide (TMZ) and irinotecan (IRI)?, in: 35 Supplement 15, «JOURNAL OF CLINICAL ONCOLOGY», 2017, pp. 11030 - 11030 (atti di: 2017 ASCO Annual Meeting, Chicago, 02 giugno - 06 giugno 2017) [atti di convegno-poster]
Emanuela Palmerini; Claudio Agostinelli; Piero Picci; Stefano A Pileri; Pier-Luigi Lollini; Katia Scotlandi; Maria Serena Benassi; Teresa Marafioti; Stefano Ferrari, Immune-infiltrate characterization in localized osteosarcoma patients treated within protocol ISG-OS1., in: Meeting Library ASCO University, 2017(atti di: 2017 ASCO Annual Meeting, Chicago, 02 giugno - 06 giugno 2017) [atti di convegno-poster]
Pinca, Rosa Simona; Manara, Maria Cristina; Chiadini, Valentina; Picci, Piero; Zucchini, Cinzia; Scotlandi, Katia, Targeting ROCK2 rather than ROCK1 inhibits Ewing sarcoma malignancy, «ONCOLOGY REPORTS», 2017, 37, pp. 1387 - 1393 [articolo]
Palmerini, Emanuela; Agostinelli, Claudio; Picci, Piero; Pileri, Stefano; Marafioti, Teresa; Lollini, Pier-Luigi; Scotlandi, Katia; Longhi, Alessandra; Benassi, Maria Serena; Ferrari, Stefano, Tumoral immune-infiltrate (IF), PD-L1 expression and role of CD8/TIA-1 lymphocytes in localized osteosarcoma patients treated within protocol ISG-OS1, «ONCOTARGET», 2017, 8, pp. 111836 - 111846 [articolo]Open Access
Mancarella, Caterina; Calzolari, Linda; Ferrari, Stefano; Donati, Davide; Picci, Piero; Scotlandi, Katia, Abstract 3201: Insulin-like growth factor 2 (IGF-2) mRNA binding protein 3 predicts poor prognosis and promotes cell proliferation in Ewing sarcoma, «CANCER RESEARCH», 2016, 76, pp. 3201 - 3201 [abstract]
Hattinger, Claudia M.; Biason, Paola; Iacoboni, Erika; Gagno, Sara; Fanelli, Marilù; Tavanti, Elisa; Vella, Serena; Ferrari, Stefano; Roli, Andrea; Roncato, Rossana; Giodini, Luciana; Scotlandi, Katia; Picci, Piero; Toffoli, Giuseppe; Serra, Massimo, Candidate germline polymorphisms of genes belonging to the pathways of four drugs used in osteosarcoma standard chemotherapy associated with risk, survival and toxicity in non-metastatic high-grade osteosarcoma, «ONCOTARGET», 2016, 7, pp. 61970 - 61987 [articolo]Open Access
Martinelli, Marcella; Parra, Alessandro; Scapoli, Luca; De Sanctis, Paola; Chiadini, Valentina; Hattinger, Claudia; Picci, Piero; Zucchini, Cinzia; Scotlandi, Katia, CD99 polymorphisms significantly influence the probability to develop Ewing sarcoma in earlier age and patient disease progression, «ONCOTARGET», 2016, 7, pp. 77958 - 77967 [articolo]
E. Palmerini;C. Agostinelli; P. Picci; S. Pileri; P. Lollini; K. Scotlandi; M.S. Benassi; S. Ferrari, PD1 and PDL1 expression, tumoral microenvironment (TME) characterization and clinical implication in localized osteosarcoma, in: Annals of Oncology, 2016(atti di: ESMO 2016, Copenhagen, 70-11 ottobre 2016) [atti di convegno-poster]
